Literature DB >> 20331958

Administrative data sets and health services research on hemoglobinopathies: a review of the literature.

Scott D Grosse1, Sheree L Boulet, Djesika D Amendah, Suzette O Oyeku.   

Abstract

CONTEXT: Large administrative healthcare data sets are an important source of data for health services research on sickle cell disease (SCD) and thalassemia. This paper identifies and describes major U.S. healthcare administrative databases and their use in published health services research on hemoglobinopathies. EVIDENCE ACQUISITION: Publications that used U.S. administrative healthcare data sets to assess healthcare use or expenditures were identified through PubMed searches using key words for SCD and either costs, expenditures, or hospital discharges; no additional articles were identified by using thalassemia as a key word. Additional articles were identified through manual searches of related articles or reference lists. EVIDENCE SYNTHESIS: A total of 26 original health services research articles were identified. The types of administrative data used for health services research on hemoglobinopathies included federal- and state-specific hospital discharge data sets and public and private health insurance claims databases. Gaps in recent health services research on hemoglobin disorders included a paucity of research related to thalassemia, few studies of adults with hemoglobinopathies, and few studies focusing on emergency department or outpatient clinic use.
CONCLUSIONS: Administrative data sets provide a unique means to study healthcare use among people with SCD or thalassemia because of the ability to examine large sample sizes at fairly low cost, resulting in greater generalizability than is the case with clinic-based data. Limitations of administrative data in general include potential misclassification, under-reporting, and lack of sociodemographic information. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20331958     DOI: 10.1016/j.amepre.2009.12.015

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  22 in total

1.  Hydroxyurea is associated with lower costs of care of young children with sickle cell anemia.

Authors:  Winfred C Wang; Suzette O Oyeku; Zhaoyu Luo; Sheree L Boulet; Scott T Miller; James F Casella; Billie Fish; Bruce W Thompson; Scott D Grosse
Journal:  Pediatrics       Date:  2013-09-02       Impact factor: 7.124

2.  Perinatal Risk Factors and Outcome Coding in Clinical and Administrative Databases.

Authors:  Daniel S Tawfik; Jeffrey B Gould; Jochen Profit
Journal:  Pediatrics       Date:  2019-01-09       Impact factor: 7.124

3.  Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees.

Authors:  Hussain R Yusuf; W Craig Hooper; Scott D Grosse; Christopher S Parker; Sheree L Boulet; Thomas L Ortel
Journal:  Thromb Res       Date:  2014-10-22       Impact factor: 3.944

4.  The revolving door of mental, neurological, and substance use disorders re-hospitalization in rural KwaZulu-Natal Province, South Africa.

Authors:  Andrew Tomita; Yoshan Moodley
Journal:  Afr Health Sci       Date:  2016-09       Impact factor: 0.927

5.  Antibiotic Prophylaxis for Children With Sickle Cell Anemia.

Authors:  Sarah L Reeves; Alison C Tribble; Brian Madden; Gary L Freed; Kevin J Dombkowski
Journal:  Pediatrics       Date:  2018-02-05       Impact factor: 7.124

6.  A National Measurement Framework to Assess and Improve Sickle Cell Care in 4 US Regions.

Authors:  Elissa Z Faro; Lisa Shook; Marsha J Treadwell; Allison A King; Lauren N Whiteman; E Donnell Ivy; Mary Hulihan; Patricia L Kavanagh; Sabrina Selk; Suzette Oyeku; Scott D Berns
Journal:  Public Health Rep       Date:  2020-07-08       Impact factor: 2.792

7.  How adequate is measles surveillance in the United States? Investigations of measles-like illness, 2010-2017.

Authors:  Susannah L McKay; Jessica Leung; Paul A Gastañaduy; Janell A Routh; Rafael Harpaz
Journal:  Hum Vaccin Immunother       Date:  2020-09-03       Impact factor: 3.452

8.  Emergency department utilization by Californians with sickle cell disease, 2005-2014.

Authors:  Susan T Paulukonis; Lisa B Feuchtbaum; Thomas D Coates; Lynne D Neumayr; Marsha J Treadwell; Elliott P Vichinsky; Mary M Hulihan
Journal:  Pediatr Blood Cancer       Date:  2016-12-21       Impact factor: 3.167

9.  The Blessing and the Curse of the Administrative Database.

Authors:  Christina S Boncyk; Christina A Jelly; Robert E Freundlich
Journal:  Ann Am Thorac Soc       Date:  2020-02

10.  Impact of hydroxyurea on clinical events in the BABY HUG trial.

Authors:  Courtney D Thornburg; Beatrice A Files; Zhaoyu Luo; Scott T Miller; Ram Kalpatthi; Rathi Iyer; Phillip Seaman; Jeffrey Lebensburger; Ofelia Alvarez; Bruce Thompson; Russell E Ware; Winfred C Wang
Journal:  Blood       Date:  2012-08-22       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.